{"meshTagsMajor":["Drug Resistance, Neoplasm"],"meshTags":["Abdominal Neoplasms","Aftercare","Brain Neoplasms","Drug Resistance, Neoplasm","Female","Humans","In Situ Hybridization, Fluorescence","Lung Neoplasms","Middle Aged","Oncogene Proteins, Fusion","Protein Kinase Inhibitors","Pyrazoles","Pyridines"],"meshMinor":["Abdominal Neoplasms","Aftercare","Brain Neoplasms","Female","Humans","In Situ Hybridization, Fluorescence","Lung Neoplasms","Middle Aged","Oncogene Proteins, Fusion","Protein Kinase Inhibitors","Pyrazoles","Pyridines"],"genes":["EML4","ALK"],"organisms":["9606"],"publicationTypes":["Case Reports","Journal Article"],"title":"Disease flare after treatment discontinuation in a patient with EML4-ALK lung cancer and acquired resistance to crizotinib.","pubmedId":"22797152"}